Letters 1. Tosto G, Bird TD, Bennett DA, et al; National Institute on Aging Late-Onset most cases in this study, there may be an overestimation of Alzheimer Disease/National Cell Repository for Alzheimer Disease benefit derived from this treatment modality as a consistent (NIA-LOAD/NCRAD) Family Study Group. The role of cardiovascular risk factors single device was not used. and stroke in familial Alzheimer disease. JAMA Neurol. 2016;73(10):1231-1237. Restoration of cerebral perfusion alone may be insuffi- 2. Dorner TE, Rieder A. Obesity paradox in elderly patients with cardiovascular cient to produce favorable outcomes ; thus, while initial diseases. Int J Cardiol. 2012;155(1):56-65. results from this study are promising, it should prompt pro- 3. Chuang Y, An Y, Bilgel M, et al. Midlife adiposity predicts earlier onset of Alzheimer’s dementia, neuropathology and presymptomatic cerebral amyloid spective trials with a larger patient cohort to evaluate the long- accumulation. Mol Psychiatry. 2016;21(7):910-915. term benefit of IA therapy in acute BAO. 4. Alhurani RE, Vassilaki M, Aakre JA, et al. Decline in weight and incident mild cognitive impairment: Mayo Clinic Study of Aging. JAMA Neurol. 2016;73(4): Alysha Bhatti, BSc 439-446. Prasanthi Sivakumaran, BSc 5. Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker
JAMA Neurology – American Medical Association
Published: Jan 28, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera